MiNK Therapeutics CEO Jennifer Buell's 2023 pay falls 27% to $2.8M
MiNK Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 29, 2024
MiNK Therapeutics reported fiscal year 2023 executive compensation information on April 29, 2024.
In 2023, three executives at MiNK Therapeutics received on average a compensation package of $1.1M, a 26% decrease compared to previous year.
Average pay of disclosed executives at MiNK Therapeutics
Jennifer S. Buell, Chief Executive Officer, received $2.8M in total, which decreased by 27% compared to 2022. 36% of Buell's compensation, or $1M, was in stock awards. Buell also received $460K in bonus, $885K in option awards, $451K in salary, as well as $5.7K in other compensation.
Marc van Dijk, Chief Scientific Officer, received a compensation package of $525K, which decreased by 19% compared to previous year. 64% of the compensation package, or $334K, was in salary.
Christine M. Klaskin, Treasurer, earned $30K in 2023, a 9% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2024.